Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
George Scangos
AddedFeb 15, 2024
UpdatedMay 31, 2026
George Scangos

George Scangos

Board Member, Agilent Technologies

CrunchbaseThe Org

George Scangos's Career

Agilent Technologies
Agilent Technologies

Santa Clara, CA, US

Board Member· Board
Rezo Therapeutics
Rezo Therapeutics

South San Francisco, CA, US

Board Member· Board
Vir Biotechnology
Vir Biotechnology

San Francisco, CA, US

Board Member· Board
Octave Bioscience
Octave Bioscience

Menlo Park, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

George Scangos's Career

Agilent Technologies
Agilent Technologies
Public$500M18k1999Santa Clara, CA, US
Board Member· Board

Leadership at Agilent Technologies

Mala AnandMala AnandBoard Member
Mikael DolstenMikael DolstenBoard Member
Paul ClarkPaul ClarkBoard Member
Heidi KunzHeidi KunzBoard Member
William HewlettWilliam HewlettCo-Founder
Mike McMullenMike McMullenCEO

Similar to Agilent Technologies

Thermo Fisher thThermo Fisher thWaltham, MA, USLaboratory Products, Scientific Instrumentsest. 2006Thermo Fisher thWaltham, MA, US · est. 2006

Global provider of scientific instruments & consumables.

Public · $119B130k
WatersWatersMilford, MA, USChromatography, Mass Spectrometryest. 1958WatersMilford, MA, US · est. 1958

Global provider of liquid chromatography products & services for various industries, based in Milford, MA.

Public · $6M8.2k
Bio-RadBio-RadHercules, CA, USDiagnostics, Life Scienceest. 1952Bio-RadHercules, CA, US · est. 1952

Bio-Rad Laboratories: A leading biotech firm specializing in life science research, clinical diagnostics, and analytical instrumentation.

Public · $1.2B8k
Hitachi High-Tech Analytical ScienceHitachi High-Tech Analytical ScienceAbingdon on Thames, Oxfordshire, GBMeasuring Technologies, Semiconductor Equipmentest. 2017Hitachi High-Tech Analytical ScienceAbingdon on Thames, Oxfordshire, GB · est. 2017

Hitachi High-Technologies: A global leader in semiconductor equipment and advanced measuring technologies since 2001.

Public200
Rezo Therapeutics
Rezo Therapeutics
Series A$78M30South San Francisco, CA, US
Board Member· Board

Leadership at Rezo Therapeutics

Norbert BischofbergerNorbert BischofbergerBoard Member
Nevan KroganNevan KroganCo-Founder
Sourav BandyopadhyaySourav BandyopadhyayCo-Founder
Vir Biotechnology
Vir Biotechnology
Public$908.6M5762016San Francisco, CA, US
Board Member· Board

Leadership at Vir Biotechnology

Phillip A. SharpPhillip A. SharpBoard Member
Elliott SigalElliott SigalBoard Member
Rob PerezRob PerezBoard Member
Louis PickerLouis PickerCo-Founder
Klaus FruehKlaus FruehCo-Founder
Vicki SatoVicki SatoBoard Member

Similar to Vir Biotechnology

Virion TherapeuticsVirion TherapeuticsNewark, DE, USImmunotherapy, Vaccinesest. 2018Virion TherapeuticsNewark, DE, US · est. 2018

Virion Therapeutics: A global biotech firm innovating vaccines for cancers and chronic viral infections.

Series B · $14.1M8
ViriomViriomSan Diego, CA, USHBV Treatments, HIV Treatmentsest. 2009ViriomSan Diego, CA, US · est. 2009

Viriom: A therapeutic biotech firm innovating treatments for HIV and Hepatitis B.

Series B · $35.4M200
Precision VirologicsPrecision VirologicsSt. Louis, MO, USBiotechest. 2016Precision VirologicsSt. Louis, MO, US · est. 2016

Precision Virologics: A St. Louis-based biotech startup innovating in virology.

Angel · $1M6
TherabiolTherabiolSan Francisco, CA, USImmune Therapiesest. 2012TherabiolSan Francisco, CA, US · est. 2012

Therabiol, Inc.: A San Francisco-based biotech firm specializing in developing immune therapies for viral infections.

Seed · $150k5
Octave Bioscience
Octave Bioscience

Menlo Park, CA, US

Board Member· Board

George Scangos's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailHiroshi MikitaniHiroshi MikitaniBoard Member · RakutenKen KutaragiKen KutaragiBoard Member · RakutenTakashi MitachiTakashi MitachiBoard Member · Rakuten

People Similar to George Scangos

Richard GonzalezRichard GonzalezBoard Member · AbbVieJeffrey LeidenJeffrey LeidenBoard Member · Vertex PharmaceuticalsReshma KewalramaniReshma KewalramaniBoard Member · Ginkgo BioworksJean-Jacques BienaimeJean-Jacques BienaimeBoard Member · Fox Chase Cancer CenterDavid LoewDavid LoewBoard Member · IpsenDave RicksDave RicksBoard Member · Eli Lilly and Company